Latest media coverage – Proactive Investors – Hemogenyx Pharmaceuticals achieves breakthrough with HEMO-CAR-T program, CBR platform

 

Annual & Half Year Reports

2023 Half Year Report Read >

Proxy Form (2023 AGM) Read >

AGM Notice (2023 AGM) Read >

2022 Annual Report (print version) Read >

2022 Annual Report (ESEF) Read >

View all